Carboplatin/Paclitaxel Preferable to Cisplatin/Paclitaxel in Optimal Stage III Epithelial Ovarian Cancer
Cyclophosphamide/Cisplatin Possibly Preferable Preferable to 32P in Treament of Early High-Risk Ovarian Cancer
Federal Funding of Pap Smears Saves Lives
Hepatic Infusion Increases Survival and Reduces Liver Metastases from Colorectal Cancer when Combined with Chemotherapy
Male Bone Density Decreases at a Steady Rate During Hormone-Suppressing Prostate Cancer Treatment
Melanoma Patients Could be Spared Radical Surgery by Sentinel Node Mapping
New Diabetes Drug Helps Cancer Cells Differentiate, Making them More Like Normal Cells
Novel Immunotherapy Targets Her2-Positive Prostate Cancer
Patients Self-Administer Protein in Nose Drops to Treat Kaposi's Sarcoma
Pre-cancerous Prostate Lesions Indicate Increased Risk of Cancer
Prophylactic Mastectomy Satisfactory to Majority of Patients
Replacing P53 Gene in Prostate Cancer Helps Shrink Tumors
Sequential Couplets of Cisplatin/Topotecan and Cisplatin/Paclitaxel as First-Line Therapy in Advanced Epithelial Ovarian Cancer
Smokers at Highest Risk of Developing Secondary Head and Neck Tumors
Tiny Radioactive Spheres Increase Survival and Reduce Liver Metastases When Combined with Chemotherapy

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información